PathoFinder
Pre-clinicalPathoFinder offers a range of panel assays for syndrome-based molecular diagnostics of infectious diseases. Our state-of-the-art multiplex PCR technologies enable rapid detection and identification of multiple human pathogens in clinical specimens.
Founded
2010
Focus
Diagnostics
About
PathoFinder offers a range of panel assays for syndrome-based molecular diagnostics of infectious diseases. Our state-of-the-art multiplex PCR technologies enable rapid detection and identification of multiple human pathogens in clinical specimens.
Funding History
2Total raised: $12.8M
Series A$10MBioGeneration VenturesMar 15, 2021
Grant$2.8MEuropean Innovation CouncilSep 15, 2020
Company Info
TypePrivate
Founded2010
LocationMaastricht, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile